← Open Payments lookup

PAUL SALADINO: Open Payments

NPI 1306951736 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$497 in 15 payments from 7 companies in 2025. Trend: 2023 $457 · 2024 $330 · 2025 $497

Food & beverage: $497
CompanyPaymentsAmount
Gilead Sciences, Inc.7$317
Alkermes, Inc.2$52
Axsome Therapeutics, Inc.2$46
ABBVIE INC.1$29
GlaxoSmithKline, LLC.1$23
Indivior Inc.1$15
Novo Nordisk Inc1$15

Products named: Yeztugo, Descovy, ARISTADA, Auvelity, VRAYLAR, TRELEGY ELLIPTA, SUBLOCADE, Ozempic.

Industry payments across NY — which companies pay providers there.